QuidelOrtho Corp (QDEL) awards 356,555 restricted stock units to CFO

Q: What equity award did QuidelOrtho (QDEL) grant to CFO Micah Young?

QuidelOrtho granted CFO Micah W. Young 356,555 restricted stock units on July 15, 2026. Each unit represents the right to receive one share of QuidelOrtho common stock, making this a substantial equity-based compensation award rather than a cash bonus.

Q: Does the QDEL CFO’s RSU grant involve any open-market stock purchases or sales?

No. The transaction is coded as an “A” grant/award acquisition of restricted stock units at a price of $0.00 per unit . It reflects equity compensation, not an open-market purchase or sale of QuidelOrtho common stock.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Young Micah W reported acquisition or exercise transactions in this Form 4 filing.

QuidelOrtho Corp granted Chief Financial Officer Micah W. Young 356,555 restricted stock units, each representing one share of common stock. The award vests in three tranches: 118,851 units on July 15, 2027, and 118,852 units on each of July 15, 2028 and July 15, 2029, all held directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Young Micah W

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	356,555	$0.00	--

Holdings After Transaction: Restricted Stock Units — 356,555 shares (Direct)

Footnotes (1)

Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. 118,851 shares will vest on July 15, 2027, 118,852 shares will vest on July 15, 2028, and 118,852 shares will vest on July 15, 2029.

Key Figures

RSUs granted: 356555.0000 Restricted Stock Units First vesting tranche: 118,851 shares Second vesting tranche: 118,852 shares +3 more

6 metrics

RSUs granted 356555.0000 Restricted Stock Units Grant to Chief Financial Officer Micah W. Young on July 15, 2026

First vesting tranche 118,851 shares Shares scheduled to vest on July 15, 2027

Second vesting tranche 118,852 shares Shares scheduled to vest on July 15, 2028

Third vesting tranche 118,852 shares Shares scheduled to vest on July 15, 2029

Price per RSU $0.0000 Grant/award acquisition price for each restricted stock unit

RSUs held after grant 356555.0000 Restricted Stock Units Total restricted stock units reported as directly held following the transaction

Key Terms

Restricted Stock Units, vest, underlying security

3 terms

Restricted Stock Units financial

"Each restricted stock unit represents the right to receive one share of common stock"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vest financial

"118,851 shares will vest on July 15, 2027, 118,852 shares will vest later"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

underlying security financial

"The underlying security title for these units is Common Stock"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/16/2026 - 04:20 PM Accepted by SEC EDGAR 07/16/2026 - 04:20 PM

FAQ

What equity award did QuidelOrtho (QDEL) grant to CFO Micah Young?

QuidelOrtho granted CFO Micah W. Young 356,555 restricted stock units on July 15, 2026. Each unit represents the right to receive one share of QuidelOrtho common stock, making this a substantial equity-based compensation award rather than a cash bonus.

How will the 356,555 RSU grant at QuidelOrtho (QDEL) vest over time?

The 356,555 restricted stock units will vest in three annual tranches: 118,851 units on July 15, 2027, and 118,852 units on each of July 15, 2028 and July 15, 2029, subject to continued service and the award’s terms.

Does the QDEL CFO’s RSU grant involve any open-market stock purchases or sales?

No. The transaction is coded as an “A” grant/award acquisition of restricted stock units at a price of $0.00 per unit. It reflects equity compensation, not an open-market purchase or sale of QuidelOrtho common stock.

How many QuidelOrtho (QDEL) RSUs does CFO Micah Young hold after this award?

Following this grant, Micah W. Young is reported as holding 356,555 restricted stock units directly. These units correspond to an equal number of underlying QuidelOrtho common shares, which will be delivered as the RSUs vest over the specified schedule.

What does each restricted stock unit granted by QuidelOrtho (QDEL) represent?

Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. As the RSUs vest on their scheduled dates, the company will deliver the corresponding number of common shares for each vested unit.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Young Micah W

(Last)

(First)

(Middle)

9975 SUMMERS RIDGE ROAD

(Street)

SAN DIEGO

CALIFORNIA

92121

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	07/15/2026		A		356,555		⁽²⁾	⁽²⁾	Common Stock	356,555	$0	356,555	D

Explanation of Responses:

1. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

2. 118,851 shares will vest on July 15, 2027, 118,852 shares will vest on July 15, 2028, and 118,852 shares will vest on July 15, 2029.

Remarks:

	/s/ Euna Greene, attorney-in-fact for Micah Young	07/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR